Aztreonam plus cefazolin: a double beta-lactam combination as empirical therapy in febrile cancer patients with or without granulocytopenia

Chemioterapia. 1987 Jun;6(2 Suppl):403-5.

Authors

F Menichetti¹, G Bucaneve, L Patoia, R Guerciolini, V Minotti, S Pauluzzi, A Del Favero

Affiliation

¹ Infectious Diseases Institute, University of Perugia, Italy.

PMID: 3334584

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Agranulocytosis / complications*
Aztreonam / therapeutic use*
Bacterial Infections / drug therapy*
Bacterial Infections / etiology
Cefazolin / therapeutic use*
Ceftriaxone / therapeutic use*
Clinical Trials as Topic
Drug Therapy, Combination / therapeutic use
Female
Fever / drug therapy*
Fever / etiology
Gram-Negative Bacteria / isolation & purification
Gram-Positive Bacteria / isolation & purification
Humans
Male
Neoplasms / complications*

Substances

Ceftriaxone
Aztreonam
Cefazolin